Lucid Diagnostics Inc.
LUCD
$1.26
-$0.03-2.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.91M | -11.54M | -12.37M | -11.01M | -10.61M |
| Total Depreciation and Amortization | 221.00K | 222.00K | 215.00K | 229.00K | 501.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.58M | 494.00K | 2.12M | 1.21M | 831.00K |
| Change in Net Operating Assets | -1.36M | 954.00K | -139.00K | -1.91M | -3.33M |
| Cash from Operations | -12.47M | -9.87M | -10.18M | -11.48M | -12.61M |
| Capital Expenditure | -93.00K | -259.00K | 0.00 | 0.00 | -37.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -350.00K | -- | -- |
| Cash from Investing | -93.00K | -259.00K | -350.00K | 0.00 | -37.00K |
| Total Debt Issued | 360.00K | 21.62M | -- | -- | -- |
| Total Debt Repaid | -- | -3.62M | -- | -- | -- |
| Issuance of Common Stock | 15.08M | 0.00 | 94.00K | 0.00 | 357.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 11.63M | 18.17M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.44M | 18.00M | 94.00K | 11.63M | 18.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.88M | 7.87M | -10.43M | 151.00K | 5.87M |